Posts

Stage 4 Breast Cancer Patient Given 2 Years to Live Survives With ‘Fourth Pillar’ of Treatments

/8 Comments/in , , /by

Less than three years ago, Tina Willits, now 53, thought she had just two years to live.

Today, she is cancer-free and wants the world to know about the treatment that saved her.

The Florida mother and grandmother first felt a lump in late 2021, just months after a normal mammogram. . .

“The doctor told me, ‘We will try to stop the progression,’ but she said ‘the best we can probably offer you is about 24 months.’” . . .

After doing some of her own research, Willits learned about an alternative treatment called immunotherapy, which uses the body’s immune system to identify and destroy cancer cells.

For decades, the go-to treatments for cancer have been chemotherapy, radiation and surgery — but some experts are calling immunotherapy the “fourth pillar” of cancer treatments. (Read more from “Stage 4 Breast Cancer Patient Given 2 Years to Live Survives With ‘Fourth Pillar’ of Treatments” HERE)

Photo credit: Flickr

The Hidden Danger in the Air That Can Cause Infertility, Colon Cancer and Lung Problems

/2 Comments/in , /by

This is rubbish!

Researchers say that deteriorating car tires and decomposing garbage are sending minute plastic fragments into the air, which may be fueling infertility, colon cancer and respiratory illnesses.

There’s long been concern about how exposure to microplastics — found in cosmetics and toothpaste and shed from food containers and clothing — can hurt humans. Growing evidence suggests that these particles smaller than a grain of rice can damage cells, trigger inflammation and disrupt the balance of bacteria in the gut.

After reviewing 3,000 studies on the matter, researchers from UC San Francisco (UCSF) concluded that microplastics are “suspected” to harm reproductive, digestive and respiratory health, with a suggested link to colon and lung cancer.

“Microplastics are basically particulate matter air pollution, and we know this type of air pollution is harmful,” said senior study author Tracey J. Woodruff, a UCSF professor of obstetrics, gynecology and reproductive sciences.

The research team reports that companies worldwide generate nearly 460 million metric tons of plastic each year — a number that is expected to rise to 1.1 billion by 2050. (Read more from “The Hidden Danger in the Air That Can Cause Infertility, Colon Cancer and Lung Problems” HERE)

Popular Cooking Ingredient Linked to Cancer Diagnoses in Young People

/0 Comments/in , , /by

Climbing rates of colon and rectal cancer among people under 50 years old is a striking recent trend that has alarmed and puzzled clinicians racing to figure out why. Now a new study published in Gut offers what might be a crucial insight: specific lipids, or fatty acids, that are abundantly found in ultra-processed foods may be promoting inflammation that causes cancerous colon cells to run amok.

Colorectal cancer tumor samples from 81 people in the U.S. had excessive amounts of inflammation-boosting lipids, called omega-6 fatty acids—and lacked helpful lipids called omega-3 fatty acids, which help stop inflammation.

Inflammation is a normal defensive response that the immune system switches on to heal wounds or fight off infection. But researchers in the 1800s found that colon tumors under a microscope looked like “poorly healed wounds,” says Timothy Yeatman, a co-author of the study and a professor of surgery at the University of South Florida. Rampant inflammation over long periods of time damages cells and hampers their ability to fight potentially cancerous cell growth. Omega-6 fatty acids often come from our diet, and Yeatman suspects ultraprocessed food is likely a major source of them.

“We don’t know the full effects of these ultraprocessed foods on our body, but we do know that that’s a major thing that’s changed from 1950 onward,” Yeatman says. “Young people today, particularly rural and impoverished people, are being exposed to more of these processed foods than anybody else because they’re cheap and they’re in all the fast-food restaurants.”

Many ultraprocessed foods and fast foods are prepared with seed oil—a cheap, common type of vegetable-based cooking oil that is chemically processed from seeds such as canola (rapeseed), corn, grapeseed and sunflower. These oils contain high amounts of omega-6 fatty acids. The study was not able to definitively connect the lipids detected in the colon cancer tumors to any specific food or oil, however. (Read more from “Popular Cooking Ingredient Linked to Cancer Diagnoses in Young People” HERE)

Photo credit: Flickr

Study: Men Who Claim They’re Women in U.S. Military May Have Gotten Cancer From Sex-Change Drug

/0 Comments/in , /by

A new case report published at Science Direct reveals that three veterans of America’s military, all men who decided they were women, got cancer, and that may have been the result of the chemicals they ingested as part of their “transition.”

The transgender agenda, one of two major ideologies being pushed onto America by the Joe Biden-Kamala Harris administration, the other being abortion for all, is misleading at best, as scientifically transgenderism cannot happen. . .

The report identified the cancer victims as men who decided they would live as females, and they took estrogen.

“Estrogens, acting through multiple pathways, have been associated with development of thyroid cancer,” the report said.

It continued, “Gender-affirming hormone therapy (GAHT) with estradiol is a cornerstone of treatment of transgender women, but thyroid cancer has been associated with estrogens. Clinicians should be aware of this and discuss it with transgender women—in the context of limited data on thyroid cancer in this population—to eliminate health disparities.” [This] report was based on case studies of “3 transgender female veterans.” (Read more from “Study: Men Who Claim They’re Women in U.S. Military May Have Gotten Cancer From Sex-Change Drug” HERE)

Photo credit: Flickr

Cancer Surge in the Young: Top Oncologist Warns of Vax Link

/0 Comments/in , , /by

In a striking revelation, Dr. Nicholas DeVito, a prominent oncologist from Duke University in North Carolina, has sounded the alarm over a disturbing trend in cancer diagnoses. According to Dr. DeVito, every new cancer patient entering his clinic is now under 45 years old. This demographic shift has raised significant concerns, as the number of young cancer patients has surged to unprecedented levels.

Dr. DeVito’s observations reflect a dramatic change in the cancer landscape. “At the start of the clinic where I see patients with colorectal, stomach, pancreatic, and other gastrointestinal cancers, I remarked to a colleague, ‘Every new patient on my schedule is under 45.’ She replied, ‘Three of mine are… this is too many young people with cancer.’ We felt as though we were in the trenches and didn’t know where the bullets were coming from,” he recounts.

This alarming trend has not gone unnoticed. Dr. DeVito and his colleagues are increasingly concerned about the rising incidence of aggressive cancers, which they refer to as “turbo cancers.” The timing of this surge coincides with the widespread rollout of COVID-19 vaccines, sparking a heated debate about a potential link between the vaccines and the rising cancer rates among younger populations.

The data showing a spike in cancer cases starting in 2021, shortly after the COVID-19 vaccines became widely available, has fueled speculation. Critics argue that the surge in cancer diagnoses could be linked to the vaccines, which were introduced as a response to the COVID-19 pandemic. These vaccines were rolled out at unprecedented speed, raising questions about their long-term effects on health.

Dr. Nicholas DeVito’s recent observations have ignited a crucial discussion about the rising incidence of cancer among young people and its potential links to the COVID-19 vaccines. As this issue continues to unfold, it is essential for all stakeholders—health officials, researchers, and the public—to engage in open and honest discussions.

Buyer Beware: Cancer Screening Is ‘Diagnosing Cancer That Isn’t Cancer’

/0 Comments/in , /by

Around the country, Americans have begun waking up to the possibility that the health care system is more interested in your wallet than it is in your cure.

Which is why extra caution should be taken when it comes to earth-shattering diagnoses like cancer.

“The ridiculous cancer screening programs that are designed to bring in customers to medical centers are diagnosing cancer that isn’t cancer,” Dr. Pam Popper, an internationally recognized expert on nutrition, medicine, and health and the founder and executive director of Wellness Forum Health tells Liz Wheeler of the “The Liz Wheeler Show.”

“In other words, ductal carcinoma in situ (DCIS) is not cancer, it’s a risk factor for breast cancer,” she continues. “A lot of people are being treated for cancer because they have risk factors, which is great for the industry, not so great for the patient.”

A major factor in preventing and/or curing cancer is diet, which conventional cancer doctors often don’t focus on.

(Read more from “Buyer Beware: Cancer Screening Is ‘Diagnosing Cancer That Isn’t Cancer’” HERE)

Model Elle Macpherson Refused Chemo Following Secret Breast Cancer Diagnosis Seven Years Ago

/0 Comments/in , /by

Supermodel Elle Macpherson is discussing a cancer diagnosis she received seven years ago and how she refused to do traditional treatments despite medical recommendations.

The 60-year-old celebrity is opening up about what happened in advance of her new book, “Elle,” which is being released in November.

“It was a shock, it was unexpected, it was confusing, it was daunting in so many ways,” Macpherson told The Australian Women’s Weekly of being diagnosed with breast cancer. “And it really gave me an opportunity to dig deep in my inner sense to find a solution that worked for me… I realized I was going to need my own truth, my belief system to support me through it. And that’s what I did.”

Despite the model’s doctor recommending a mastectomy with chemotherapy, radiation, and hormone therapy, Macpherson opted for “an intuitive, heart-led, holistic approach” instead, which earned her mixed reactions from family members. . .

“I chose a holistic approach. Saying no to standard medical solutions was the hardest thing I’ve ever done in my life. But saying no to my own inner sense would have been even harder,” she wrote in her book. (Read more from “Model Elle Macpherson Refused Chemo Following Secret Breast Cancer Diagnosis Seven Years Ago” HERE)

Evidence of ‘Extraordinary’ Cancer Treatment Found in 4,000-Year-Old Egyptian Skull

/0 Comments/in , , /by

By New York Post. An international team of researchers says it has found evidence of ancient Egyptians performing experimental treatments or medical explorations of human cancer more than 4,000 years ago.

“This is an extraordinary new perspective in our understanding of the history of medicine,” said Edgard Camarós, a paleopathologist at the University of Santiago de Compostela in Spain and lead author of the study, which was published Wednesday in the Frontiers in Medicine journal.

Photo credit: Tondini, Isidro, Camarós, 2024/Frontiers

Camarós’ team examined two human skulls from the University of Cambridge’s Duckworth Collection in the UK. The first, of a man 30 to 35 years old, dates back to between 2687 and 2345 BC. The second one, of a woman older than 50, is from 663 to 343 BC.

Researchers noted that the man had a tumor — they observed about 30 small round lesions scattered across his skull. The researchers were stunned to discover that someone had cut around the lesions, seemingly with a sharp object. . .

The Cancer History Project reports that the earliest description of human cancer dates back to Egypt from around 3000 BC. The Greek physician Hippocrates (460-370 BC) is credited with first calling the disease cancer. (Read more from “Evidence of ‘Extraordinary’ Cancer Treatment Found in 4,000-Year-Old Egyptian Skull” HERE)

_____________________________________________________

Evidence of Surgical Tumor Removal in Ancient Egyptian Skull Is ‘Milestone in the History of Medicine’

By CNN. . .However, it’s unknown whether the healers tried to remove the tumors while the patient was still alive, or if the tumors were removed after death, for analysis, Camarós told CNN.

“If those cut marks were done with that person alive, we’re talking about some kind of treatment directly related to the cancer,” he said. But if the cut marks were made posthumously, “it means that this is a medical autopsy exploration in relation to that cancer.”

Either way, “it’s amazing to think that they performed a surgical intervention,” Camarós added. “But we cannot actually distinguish between a treatment and an autopsy.”

Medicine in ancient Egypt, documented extensively in medical texts such as the Ebers Papyrus and the Kahun Papyrus, was unquestionably sophisticated, and the new findings offer important, direct evidence of this knowledge, said Dr. Ibrahem Badr, an associate professor in the department of restoration and conservation of antiquities at Misr University for Science and Technology in Giza, Egypt.

“We can see that ancient Egyptian medicine was not solely based on herbal remedies like medicine in other ancient civilizations,” said Badr, who was not involved in the new research. “It directly relied on surgical practices.” (Read more from “Evidence of Surgical Tumor Removal in Ancient Egyptian Skull Is ‘Milestone in the History of Medicine’” HERE)

Doctor Cancer-Free One Year After Using Own Revolutionary Treatment on Terminal Brain Tumor

/1 Comment/in , , /by

An Australian doctor who was diagnosed with a terminal brain tumor last year is cancer-free thanks to a first-of-its-kind treatment that he helped to develop.

Richard Scolyer, a professor at the University of Sydney, revealed Monday that the incurable stage 4 glioblastoma discovered in his head has not recurred after receiving the heartbreaking diagnosis last June.

“I had brain #MRI scan last Thursday looking for recurrent #glioblastoma (&/or treatment complications). I found out yesterday that there is still no sign of recurrence. I couldn’t be happier!!!!!” the professor shared on X.

In May 2023, the fit educator was traveling throughout Europe speaking at medical conferences when he suffered a seizure while in Poland.

Scolyer flew back to Australia, where he underwent an MRI that revealed he had a glioblastoma, an aggressive and terminal form of brain cancer, with his subtype being classified as so aggressive most patients don’t survive longer than a year, according to the BBC. (Read more from “Doctor Cancer-Free One Year After Using Own Revolutionary Treatment on Terminal Brain Tumor” HERE)

Pfizer Settles Over 10,000 Cancer Lawsuits

/1 Comment/in , , /by

In a development that has largely flown under the radar, pharmaceutical giant Pfizer has quietly agreed to settle over 10,000 lawsuits tied to cancer risks associated with the popular antacid Zantac, according to federal prosecutors.

The lawsuits alleged that Pfizer concealed the cancer risks posed by Zantac, a widely used heartburn medication. The settlements cover cases filed across state courts in the United States, although the financial details of the agreements have not been disclosed to the public.

While the settlements mark a significant step in resolving the litigation surrounding Zantac, they do not entirely absolve Pfizer of its exposure to claims related to the drug. The news of the settlements is likely to provide some relief to investors, as concerns about the potential financial liabilities stemming from Zantac lawsuits had previously impacted the company’s market value.

Pfizer’s decision to settle comes amidst ongoing scrutiny over the safety and transparency of pharmaceutical products. Critics argue that the case highlights broader issues within the pharmaceutical industry, including allegations of deceptive marketing practices and suppression of critical information regarding product safety.

The controversy surrounding Zantac adds to the growing list of concerns surrounding Pfizer and other pharmaceutical companies, particularly in light of the COVID-19 pandemic. While Pfizer has emphasized that it ceased the production of Zantac more than 15 years ago, questions remain about the company’s handling of the drug and its potential health risks.

Despite the settlement, the fallout from the Zantac litigation underscores broader concerns about the pharmaceutical industry’s accountability and the need for increased transparency in drug safety regulation.